Palisade Bio, Inc. (NASDAQ:PALI) Financings

Palisade Bio, Inc.

Financings

RaiseDate
Strategic investment of equity
Announced: up to US$500,000
Buyers: Crohn’s & Colitis Foundation (IBD Ventures program) (strategic equity investment of up to $500,000)
Use of proceeds: Continued clinical and mechanistic development of PALI-2108 for fibrostenotic Crohn's disease and ulcerative colitis
Jan 7, 2026
Public offering of common stock (or common stock equivalents)
Closed: US$138M raised · US$0.7 a share · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Buyers: B Group Capital (led the offering); Columbia Threadneedle Investments (led the offering); Adage Capital Partners LP (significant participation); ADAR1 Capital Management (significant participation); Boxer Capital Management (significant participation); Coastlands Capital (significant participation); Deep Track Capital (significant participation); Janus Henderson Investors (significant participation); Octagon Capital (significant participation); Perceptive Advisors (significant participation); RA Capital Management (significant participation); Squadron Capital Management (significant participation)
Use of proceeds: To support the upcoming Phase 2 clinical development program for PALI-2108 in ulcerative colitis
Oct 2, 2025
Warrant exercise of existing warrants to purchase common stock
Announced: about US$3.9M · US$0.9047 a share · Warrants at US$0.9047 for 60 months · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Use of proceeds: Working capital and general corporate purposes
Jul 24, 2025
Public offering of class A Units and Class B Units (common stock or prefunded warrants with common warrants)
Announced: about US$5M · US$1.525 a unit · Warrants at US$1.4 for 60 months · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Use of proceeds: Phase 1 clinical trial of PALI-2108, pre-clinical studies, research and development, and working capital
Dec 12, 2024

Read by 6ix AI from the company's releases